Patents by Inventor YU-WEI HSIAO

YU-WEI HSIAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9610325
    Abstract: The invention relates to a method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by an amino acid sequence, comprising administering an effective amount of the amino acid sequence to a subject in need. The amino acid sequence can be used to inhibit euPTX3 from promoting the migration and invasion of nasopharyngeal carcinoma cells, promoting angiogenesis and inhibiting macrophage phagocytosis to further treat nasopharyngeal carcinoma.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: April 4, 2017
    Assignee: NATIONAL CHENG KUNG UNIVERSITY
    Inventors: Ju-Ming Wang, Yu-Wei Hsiao, Jhih-Ying Chi, Shao-Ming Wang
  • Publication number: 20160347800
    Abstract: The present invention relates to a short peptide-based therapeutic agent and a medicinal composition including the same for inhibiting activities of cancer cells, which includes at least one short peptide listed as SEQ ID NOs: 1 and 2, either of which is unglycosylated and has no more than 40 amino acid residues, thereby specifically reducing or inhibiting activities of cancer cells such as the cancer cell proliferation, cancer stemness, cell migration, cancer cell invasion, metastasis or drug resistance.
    Type: Application
    Filed: September 1, 2015
    Publication date: December 1, 2016
    Inventors: Ju-Ming WANG, Yu-Wei HSIAO, Jhih-Ying CHI
  • Publication number: 20150025018
    Abstract: The invention relates to a method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by an amino acid sequence, comprising administering an effective amount of the amino acid sequence to a subject in need. The amino acid sequence can be used to inhibit euPTX3 from promoting the migration and invasion of nasopharyngeal carcinoma cells, promoting angiogenesis and inhibiting macrophage phagocytosis to further treat nasopharyngeal carcinoma.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 22, 2015
    Inventors: JU-MING WANG, YU-WEI HSIAO
  • Publication number: 20140364374
    Abstract: The invention relates to an amino acid sequence for inhibiting PTX3 to treat nasopharyngeal carcinoma. It can be used to inhibit PTX3 from promoting the migration and invasion of nasopharyngeal carcinoma cells, promoting angiogenesis and inhibiting macrophage phagocytosis to further treat nasopharyngeal carcinoma.
    Type: Application
    Filed: October 2, 2013
    Publication date: December 11, 2014
    Applicant: NATIONAL CHENG KUNG UNIVERSITY
    Inventors: JU-MING WANG, YU-WEI HSIAO